These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 27905217)
21. Application of genome editing technologies to the study and treatment of hematological disease. Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620 [TBL] [Abstract][Full Text] [Related]
22. [Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals]. Li GL; Yang SX; Wu ZF; Zhang XW Yi Chuan; 2020 Jul; 42(7):641-656. PubMed ID: 32694104 [TBL] [Abstract][Full Text] [Related]
24. Plant genome engineering in full bloom. Lozano-Juste J; Cutler SR Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878 [TBL] [Abstract][Full Text] [Related]
25. Genome Editing: A New Horizon for Oral and Craniofacial Research. Yu N; Yang J; Mishina Y; Giannobile WV J Dent Res; 2019 Jan; 98(1):36-45. PubMed ID: 30354846 [TBL] [Abstract][Full Text] [Related]
26. Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies. Amritha PP; Shah JM Mol Genet Genomics; 2021 May; 296(3):485-500. PubMed ID: 33751237 [TBL] [Abstract][Full Text] [Related]
27. A comprehensive overview of computational resources to aid in precision genome editing with engineered nucleases. Periwal V Brief Bioinform; 2017 Jul; 18(4):698-711. PubMed ID: 27373734 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic Genome Editing and In Vivo Delivery. Ramirez-Phillips AC; Liu D AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099 [TBL] [Abstract][Full Text] [Related]
29. CRISPR-Cas9 system: A new-fangled dawn in gene editing. Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471 [TBL] [Abstract][Full Text] [Related]
30. Evolution in crop improvement approaches and future prospects of molecular markers to CRISPR/Cas9 system. Dheer P; Rautela I; Sharma V; Dhiman M; Sharma A; Sharma N; Sharma MD Gene; 2020 Aug; 753():144795. PubMed ID: 32450202 [TBL] [Abstract][Full Text] [Related]
31. Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification. Pu J; Frescas D; Zhang B; Feng J Exp Biol Med (Maywood); 2015 Aug; 240(8):1065-70. PubMed ID: 25956682 [TBL] [Abstract][Full Text] [Related]
32. Delivery technologies for genome editing. Yin H; Kauffman KJ; Anderson DG Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020 [TBL] [Abstract][Full Text] [Related]
33. Targeted genome editing tools for disease modeling and gene therapy. Cai M; Yang Y Curr Gene Ther; 2014 Feb; 14(1):2-9. PubMed ID: 24665839 [TBL] [Abstract][Full Text] [Related]
34. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems. Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234 [TBL] [Abstract][Full Text] [Related]
35. Genome Editing for the Study of Cardiovascular Diseases. Chadwick AC; Musunuru K Curr Cardiol Rep; 2017 Mar; 19(3):22. PubMed ID: 28220462 [TBL] [Abstract][Full Text] [Related]
36. Non-viral delivery of genome-editing nucleases for gene therapy. Wang M; Glass ZA; Xu Q Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355 [TBL] [Abstract][Full Text] [Related]